Noncoding SNPs decrease expression of FABP5 during COPD exacerbations

J Clin Invest. 2023 Dec 19;134(3):e175626. doi: 10.1172/JCI175626.

Authors

Manale El Kharbili¹, Sarah K Sasse², Lynn Sanford³, Sean Jacobson², Katja Aviszus¹, Arnav Gupta^{2

4}, Claire Guo², Susan M Majka², Robin D Dowell^{3

5

6}, Anthony N Gerber^{1

2

4}, Russell P Bowler², Fabienne Gally^{1

4}

Affiliations

¹ Department of Immunology and Genomic Medicine and.
² Department of Medicine, National Jewish Health, Denver, Colorado, USA.
³ BioFrontiers Institute.
⁴ Department of Medicine.
⁵ Molecular, Cellular and Developmental Biology, and.
⁶ Computer Science, University of Colorado, Boulder, Colorado, USA.

No abstract available

Keywords: COPD; Genetics; Metabolism.

MeSH terms

Disease Progression
Fatty Acid-Binding Proteins / genetics
Fatty Acid-Binding Proteins / metabolism
Humans
Polymorphism, Single Nucleotide*
Pulmonary Disease, Chronic Obstructive* / genetics
Risk Factors

Substances

FABP5 protein, human
Fatty Acid-Binding Proteins

Grants and funding